Alnylam Pharmaceuticals · 1 day ago
Senior Scientist, Cell Biology
United States
Full-time
Remote
Senior Level
$126K/yr - $190K/yr
2+ years expAlnylam Pharmaceuticals is a leader in RNAi therapeutics, and they are seeking a highly motivated Senior Scientist in Delivery Biology to support targeted delivery strategies for siRNA-based therapeutics. The role focuses on mechanistic cell biology to improve delivery across tissues and cell types, requiring excellent collaboration and communication skills.
BiotechnologyHealthcarePharmaceuticalHealth CareMedicalTherapeutics
No H1B
Responsibilities
Develop and apply assays and experimental strategies to interrogate trafficking biology
Design, execute, and interpret cell‑based assays to evaluate delivery efficiency and biological outcomes
Identify cell types or tissues that require novel or optimized delivery approaches
Collaborate extensively with cross‑functional partners focused on expanding targeted delivery into new cell types and tissues
Transparently communicate data, conclusions, and experimental rationale to team members and leadership
Mentor and support the scientific development of junior scientists or research associates
Qualification
Required
PhD in Cell Biology, Molecular Biology, Immunology, Biochemistry or related field
2-3 years of experience in biopharma setting
Strong expertise in cell biology, particularly intracellular trafficking, receptor biology, or related mechanisms
Experience in microscopy and biochemical techniques related to cell-based studies
Experience designing and interpreting both in vitro and in vivo experiments
Demonstrated scientific rigor, attention to detail and data reproducibility
Excellent communication and interpersonal skills, with the ability to effectively collaborate across multidisciplinary teams
Preferred
Experience with ligand-based delivery, conjugates or receptor biology preferred
Benefits
Annual short-term incentive award (e.g., bonus or sales incentive)
Annual long-term incentive award (e.g., equity)
Medical, dental, and vision coverage
Life and disability insurance
A lifestyle reimbursement program
Flexible spending and health savings accounts
401(k)with a generous company match
Paid time off
Wellness days
Holidays
Two company-wide recharge breaks
Generous family resources and leave
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Leadership Team
Yvonne Greenstreet
Chief Executive Officer
Jeff Poulton
Chief Financial Officer
Recent News
BioWorld Financial Watch
2026-07-18
2026-07-10
Company data provided by crunchbase